Alakurtti S - Search Results

1

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening.

Kirstgen M, Müller SF, Lowjaga KAAT, Goldmann N, Lehmann F, Alakurtti S, Yli-Kauhaluoma J, Baringhaus KH, Krieg R, Glebe D, Geyer J. Kirstgen M, et al. Among authors: alakurtti s. Viruses. 2021 Jul 29;13(8):1489. doi: 10.3390/v13081489. Viruses. 2021. PMID: 34452354 Free PMC article.

2

Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids.

Kirstgen M, Lowjaga KAAT, Müller SF, Goldmann N, Lehmann F, Alakurtti S, Yli-Kauhaluoma J, Glebe D, Geyer J. Kirstgen M, et al. Among authors: alakurtti s. Sci Rep. 2020 Dec 10;10(1):21772. doi: 10.1038/s41598-020-78618-2. Sci Rep. 2020. PMID: 33303817 Free PMC article.

3

Pharmacological properties of the ubiquitous natural product betulin.

Alakurtti S, Mäkelä T, Koskimies S, Yli-Kauhaluoma J. Alakurtti S, et al. Eur J Pharm Sci. 2006 Sep;29(1):1-13. doi: 10.1016/j.ejps.2006.04.006. Epub 2006 Apr 29. Eur J Pharm Sci. 2006. PMID: 16716572 Review.

4

Betulin-derived compounds as inhibitors of alphavirus replication.

Pohjala L, Alakurtti S, Ahola T, Yli-Kauhaluoma J, Tammela P. Pohjala L, et al. Among authors: alakurtti s. J Nat Prod. 2009 Nov;72(11):1917-26. doi: 10.1021/np9003245. J Nat Prod. 2009. PMID: 19839605

5

Screening and characterisation of antimicrobial properties of semisynthetic betulin derivatives.

Haque S, Nawrot DA, Alakurtti S, Ghemtio L, Yli-Kauhaluoma J, Tammela P. Haque S, et al. Among authors: alakurtti s. PLoS One. 2014 Jul 17;9(7):e102696. doi: 10.1371/journal.pone.0102696. eCollection 2014. PLoS One. 2014. PMID: 25032708 Free PMC article.

6

Anti-leishmanial activity of betulin derivatives.

Alakurtti S, Bergström P, Sacerdoti-Sierra N, Jaffe CL, Yli-Kauhaluoma J. Alakurtti S, et al. J Antibiot (Tokyo). 2010 Mar;63(3):123-6. doi: 10.1038/ja.2010.2. Epub 2010 Feb 5. J Antibiot (Tokyo). 2010. PMID: 20139867

7

Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12).

Parkkari T, Haavikko R, Laitinen T, Navia-Paldanius D, Rytilahti R, Vaara M, Lehtonen M, Alakurtti S, Yli-Kauhaluoma J, Nevalainen T, Savinainen JR, Laitinen JT. Parkkari T, et al. Among authors: alakurtti s. PLoS One. 2014 May 30;9(5):e98286. doi: 10.1371/journal.pone.0098286. eCollection 2014. PLoS One. 2014. PMID: 24879289 Free PMC article.

8

Betulin derivatives impair Leishmania braziliensis viability and host-parasite interaction.

Alcazar W, López AS, Alakurtti S, Tuononen ML, Yli-Kauhaluoma J, Ponte-Sucre A. Alcazar W, et al. Among authors: alakurtti s. Bioorg Med Chem. 2014 Nov 1;22(21):6220-6. doi: 10.1016/j.bmc.2014.08.023. Epub 2014 Aug 28. Bioorg Med Chem. 2014. PMID: 25240731

9

Abietane-Type Diterpenoid Amides with Highly Potent and Selective Activity against Leishmania donovani and Trypanosoma cruzi.

Pirttimaa M, Nasereddin A, Kopelyanskiy D, Kaiser M, Yli-Kauhaluoma J, Oksman-Caldentey KM, Brun R, Jaffe CL, Moreira VM, Alakurtti S. Pirttimaa M, et al. Among authors: alakurtti s. J Nat Prod. 2016 Feb 26;79(2):362-8. doi: 10.1021/acs.jnatprod.5b00990. Epub 2016 Feb 5. J Nat Prod. 2016. PMID: 26849852

10

Pyrazine-Fused Triterpenoids Block the TRPA1 Ion Channel in Vitro and Inhibit TRPA1-Mediated Acute Inflammation in Vivo.

Mäki-Opas I, Hämäläinen M, Moilanen LJ, Haavikko R, Ahonen TJ, Alakurtti S, Moreira VM, Muraki K, Yli-Kauhaluoma J, Moilanen E. Mäki-Opas I, et al. Among authors: alakurtti s. ACS Chem Neurosci. 2019 Jun 19;10(6):2848-2857. doi: 10.1021/acschemneuro.9b00083. Epub 2019 Apr 29. ACS Chem Neurosci. 2019. PMID: 31034197 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page